Benign and Malignant Neoplasms Affecting Periodontal Tissues: A Retrospective Study

Abstract

Introduction: Oral neoplasms are the second most common oral lesions after reactive proliferative lesions. The aim of this study is to determine the distribution of the oral neoplasms by gender and age, and briefly discussed the clinical manifestations, diagnosis, and treatments of these lesions. Materials and Methods: To collect the study material, a pathological retrospective archive analysis has been performed and 61 oral neoplasm cases were determined in a total of 423 samples. 61 biopsies and clinical data of patients were studied and classified based on their histopathologic diagnosis, age, gender, and frequency. Results: In our study, a total of 61 neoplastic lesions were examined, and the mean age was 45.5 ±18.2. The most common lesion in the oral neoplastic lesion is leukoplakia (n=15, 24.59%). This is followed by squamous cell carcinoma (SCC) (n =13, 21.31%) and squamous papilloma (n =11, 18.03%). The rest are gingival granular cell tumor, hemangioma, odontoma, lipoma, mucosal nevus, myxoma, ameloblastoma, leukemia, melanoma, lymphoma, and osteosarcoma. Conclusion: This study provided important data on the frequency and histological distribution of oral benign and malign neoplasms. This study also highlights the diagnosis, and management of these oral neoplasms for the dentists.

Keywords

• Oral neoplasm
• Squamous cell carcinoma
• Leukoplakia

References

1. 1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. Mar-Apr 2005;55(2):74-108.
2. 2. Soo KC, Spiro RH, King W, Harvey W, Strong EW. Squamous carcinoma of the gums. Am J Surg. 1988 Oct;156(4):281-5.
3. 3. Shingaki S, Nomura T, Takada M, Kobayashi T, Suzuki I, Nakajima T. Squamous cell carcinomas of the mandibular alveolus: analysis of prognostic factors. Oncology. 2002;62(1):17-24.
4. 4. Gomez D, Faucher A, Picot V, Siberchicot F, Renaud-Salis JL, Bussières E, et al. Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg. 2000 Dec;28(6):331-5.
5. 5. Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013 Feb;63(1):12-25.
6. 6. Rich AM, Seo B, Parachuru V, Hussaini HM. The nexus between periodontics and oral pathology. Periodontol 2000. 2017 Jun;74(1):176-181.
7. 7. Rao SVK, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade-an update (2000-2012). Asian Pac J Cancer Prev. 2013;14(10):5567-77.
8. 8. Ali M, Sundaram D. Biopsied oral soft tissue lesions in Kuwait: a six-year retrospective analysis. Med Princ Pract. 2012;21(6):569-75.

9. 9. Dhanuthai K, Rojanawatsirivej S, Somkotra T, Shin HI, Hong SP, Hong SP, et al. Geriatric oral lesions: A multicentric study. Geriatr Gerontol Int. 2016 Feb;16(2):237-43.
10. 10. Wang YL, Chang HH, Chang JYF, Huang GF, Guo MK. Retrospective survey of biopsied oral lesions in pediatric patients. J Formos Med Assoc. 2009 Nov;108(11):862-71.
11. 11. Silverman S, Bhargava K, Mani NJ, Smith LW, Malaowalla AM. Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer, 1969 October; 24(4):832-49.
12. 12. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980;8(6):283-333.
13. 13. Feng J, Zhou Z, Shen X, Wang Y, Shi L, Wang Y, et al. Prevalence and distribution of oral mucosal lesions: a cross-sectional study in Shanghai, China. J Oral Pathol Med. 2015 Aug;44(7):490-4.
14. 14. Naik S, Nidoni M. Oral squamous papilloma of the palate – A case report. Int J Clin Pediatr Dent. May-Jun 2018;11(3):244-246.
15. 15. Abbey LM, Page DG, Sawyer DR. The clinical and histopathologic features of a series of 464 oral squamous cell papillomas. Oral Surg Oral Med Oral Pathol. 1980 May;49(5):419-28.
16. 16. Song WS, Kim JW, Kim YG, Ryu DM. A case report of congenital epulis in the fetus.J Oral Maxillofac Surg. 2005 Jan;63(1):135-7.
17. 17. Inan M, Yalcin O, Pul M. Congenital fibrous epulis in the infant. Yonsei Med J. 2002 Oct;43(5):675-7.
18. 18. Berhoft CH, Gilhuus-Moe O, Bang G. Congenital epulis in the newborn. Int J Pediatr Otorhinolaryngol. 1987 Jun;13(1):25-9.
19. 19. Bilen BT, Alaybeyoglu N, Arslan A, Türkmen E, Aslan S, Celik M. Obstructive congenital gingival granular cell tumour. Int J Pediatr Otorhinolaryngol. 2004 Dec;68(12):1567-71.
20. 20. Kusukawa J, Kuhara S, Koga C. Congenital epulis review of the literature and case report. J Oral Maxillofac Surg. 1993 Sep;51(9):1040-3.
21. 21. Maaita JK. Oral tumors in children: a review. J Clin Pediatr Dent. Winter 2000;24(2):133-5.
22. 22. Tanaka N, Murata A, Yamaguchi A, Kohama G. Clinical features and management of oral and maxillofacial tumors in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jul;88(1):11-5.
23. 23. Shafer WG, Hine MK, Levy BM. Textbook of Oral Pathology, 4th ed. Philadelphia: WB Saunders Co, Pp. 154–157.
24. 24. Colyer JF, Sprawson E. Dental surgery and Pathology 4th ed. London: Butterworth and Co, Pp. 1042–1045.
25. 25. Dilley DC, Siegel MA, Budnick S. Diagnosing and treating common oral pathologies. Pediatr Clin North Am. 1991 Oct;38(5):1227-64.
26. 26. Carranza F.A. Glickman's Clinical Periodontology; 1st ed. Philadelphia: WB Saunders Co London, pp. 335–351.
27. 27. Budnick SD. Compound and complex odontomas. Oral Surg Oral Med Oral Pathol. 1976 Oct;42(4):501–506.
28. 28. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. Philadelphia, PA: Saunders, 531–533.
29. 29. Boffano P, Zavattero E, Roccia F, Gallesio C. Complex and compound odontomas. J Craniofac Surg. 2012 May;23(3):685-8.
30. 30. Ochsenius G, Ortega A, Godoy L, Peñafiel C, Escobar E. Odontogenic tumors in Chile: a study of 362 cases. J Oral Pathol Med. 2002 Aug;31(7):415-20.
31. 31. Siriwardena BSM., Crane H, O'Neill N, Abdelkarim R, Brierley DJ, Franklin CD, et al. Odontogenic tumors and lesions treated in a single specialist oral and maxillofacial pathology unit in the United Kingdom in 1992-2016. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):151-166.
32. 32. Fregnani ER, Pires FR, Falzoni R, Lopes MA, Vargas PA. Lipomas of the oral cavity: clinical findings, histological classification and proliferative activity of 46 cases. Int J Oral Maxillofac Surg. 2003 Feb;32(1):49-53. 33. Furlong MA, Fanburg-Smith JC, Childers ELB. Lipoma of the oral and maxillofacial region: Site and subclassification of 125 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Oct;98(4):441-50.
33. 34. Heffel DF, Thaller S. Congenital melanosis: an update. J Craniofac Surg. 2005 Sep;16(5):940-4.
34. 35. Meleti M, Mooi WJ, Casparie MK, van der Waal I. Melanocytic nevi of the oral mucosa—no evidence of increased risk for oral malignant melanoma: an analysis of 119 cases. Oral Oncol. 2007 Nov;43(10):976-81.
35. 36. Buchner A, Leider AS, Merrell PW, Carpenter WM. Melanocytic nevi of the oral mucosa: a clinicopathologic study of 130 cases from northern California. J Oral Pathol Med. 1990 May;19(5):197-201.
36. 37. Kramer IRH, Pindborg JJ, Shear M. Histological typing of odontogenic tumours. 2nd ed. Berlin: Springer Verlag, pp. 23.
37. 38. Regezi JA, Kerr DA, Courtney RM. Odontogenic tumours: an analysis of 109 cases. J Oral Surg. 1978 Oct;36(10):771-8.
38. 39. Daley TD, Wysocki GP, Pringle GA. Relative incidence of odontogenic tumours and oral and jaw cysts in a Canadian population. Oral Surg Oral Med Oral Pathol. 1994 Mar;77(3):276-80.
39. 40. Adekeye E.O., Avery B.S., Edwards M.B., Williams H.K. (1984). Advanced central myxoma of the jaws in Nigeria: clinical features, treatment and pathogenesis. Int J Oral Surg, doi: 10.1016/s0300-9785(84)80001-0.
40. 41. Abiose BO, Ajagbe HA, Thomas O. Fibromyxomas of the jawbones–a study of 10 cases. Br J Oral Maxillofac Surg. 1987 Oct;25(5):415-21.
41. 42. Fernandes AM, Duarte EC, Pimenta FJ, Souza LN, Santos VR, Mesquita RA, et al. Odontogenic tumors: a study of 340 cases in a Brazilian population. J Oral Pathol Med. 2005 Nov;34(10):583-7.
42. 43. Ladeinde AL, Ogunlewe MO, Bamgbose BO, Adeyemo WL, Ajayi OF, Arotiba GT, et al. Ameloblastoma: analysis of 207 cases in a Nigerian teaching hospital. Quintessence Int. 2006 Jan;37(1):69-74.
43. 44. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99.
44. 45. Namin AK, Azad TM, Eslami B, Sarkarat F, Shahrokhi M, Kashanian F. A study of the relationship between ameloblastoma and human papilloma virus. J Oral Maxillofac Surg. 2003 Apr;61(4):467-70.
45. 46. Kumamoto H, Ooya K. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas. J Oral Pathol Med. 2006 Mar;35(3):183-9.
46. 47. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80.
47. 48. Anderson A, Ishak N. Marked variation in malignant transformation rates of oral leukoplakia. Evid Based Dent. 2015 Dec;16(4):102-3.
48. 49. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer. 1975 Oct;36(4):1386-92.
49. 50. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. Jul-Aug 2002;52(4):195-215.
50. 51. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN–a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010 Jun;49(5):725-36.
51. 52. Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, et al. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415.
52. 53. Pires FR, Ramos AB, de Oliveira JBC, Tavares AS, de Luz PSR, dos Santos TCRB. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci. Sep-Oct 2013;21(5):460-7.
53. 54. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017 Aug;66:10-12.
54. 55. Rodrigues PC, Miguel MCC, Bagordakis E, Fonseca FP, De Aquino SN, Santos-Silva AR, et al. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg. 2014 Jul;43(7):795-801.
55. 56. Dissanayaka WL, Pitiyage G, Kumarasiri PVR, Liyanage RLPR, Dias KD, Tilakaratne WM. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Apr;113(4):518-25.
56. 57. Elaiwy O, El Ansari W, Al Khalil M, Ammar A. Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: Retrospective study of 154 cases over 7 years in Qatar. Ann Med Surg (Lond). 2020 Oct 20;60:195-200.
57. 58. Cotran RS, Kumar V, Collins T. White cells and lymph nodes. In ‘Robbins pathologic basis of disease’, Eds, Pp. 657-658.
58. 59. Reenesh M, Munishwar S, Rath SK. Generalised leukaemic gingival enlargement: a case report. J Oral Maxillofac Res. 2012 Oct 1;3(3):e5.
59. 60. Hou GL, Huang JS, Tsai CC. Analysis of oral manifestations of leukemia: a retrospective study. Oral Dis. 1997 Mar;3(1):31-8.
60. 61. Fernandes KS, Gallottini M, Castro T, Amato MF, Lago JS, Braz-Silva PH. Gingival leukemic infiltration as the first manifestation of acute myeloid leucemia. Spec Care Dentist. 2018 May;38(3):160-162.
61. 62. Chatzistefanou I, Kolokythas A, Vahtsevanos K, Antoniades K. Primary mucosal melanoma of the oral cavity: current therapy and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Jul;122(1):17-27.
62. 63. Mohan M, Sukhadia VY, Pai D, Bhat S. Oral malignant melanoma: systematic review of literature and report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Oct;116(4):e247-54.
63. 64. Bakkal FK, Basman A, Kizil Y, Ekinci Ö, Gümüşok M, Zorlu ME, et al. Mucosal melanoma of the head and neck: recurrence characteristics and survival outcomes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Nov;120(5):575-80.
64. 65. Williams MD. Update from the 4th edition of the world health organization classification of head and neck tumours: mucosal melanomas. Head Neck Pathol. 2017 Mar;11(1):110-117.
65. 66. Muller S. Melanin-associated pigmented lesions of the oral mucosa: presentation, differential diagnosis, and treatment. Dermatol Ther. May-Jun 2010;23(3):220-9.
66. 67. De Pena CA, Van Tassel P, Lee YY. Lymphoma of the head and neck. Radiol Clin North Am. 1990 Jul;28(4):723-43.
67. 68. Jordan RC, Speight PM. Extranodal non-Hodgkin’s lymphomas of the oral cavity. Curr Top Pathol. 1996;90:125-46.
68. 69. Otter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin’s lymphoma: A survey of a population-based registry. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1203-10.
69. 70. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Nov;92(5):519-25.
70. 71. Kemp S, Gallagher G, Kabani S, Noonan V, O'Hara C. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):194-201.
71. 72. Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics Review, 1975–2004, Based on November 2006 SEER Data Submission. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2004/; Accessed January 2009.